The reduction in AUC after oral administration can result from numerous mechanisms including: pH or bacterial-mediated metabolism of the drug within the GI tract, incomplete drug absorption from the GI tract, metabolism within the GI epithelium (which contains CYP3A4), excretion back into the GI tract by P-glycoprotein in the GI epithelium, hepatic metabolism, or biliary excretion into the GI tract
this suggests the counteraction of the chain of events that otherwise leads to painful sensations and refers to denervated regions and the preservation of one or more spinal segments [41]
What it does to you, through a cream or anything else, is a question the dish was never built to answer
If amycretin's early data holds in phase 3, its oral availability could make it the preferred option
This article covers the specific mechanisms that limit oral bioavailability, how alternative delivery routes improve absorption, and what the limited human data actually shows about Dihexa's pharmacokinetics